Global Liver Cirrhosis Clinical Trial Pipeline Report 2021-2025: Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Preclinical Research, and Discovery Stage - ResearchAndMarkets.com

·2 min read

The "Global Liver Cirrhosis Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering.

The latest report Liver Cirrhosis Pipeline Highlights - 2021, provides the most up-to-date information on key pipeline products in the global Liver Cirrhosis market. It covers emerging therapies for Liver Cirrhosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Liver Cirrhosis pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Liver Cirrhosis pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Liver Cirrhosis pipeline products by the company.

Short-term Launch Highlights:

Find out which Liver Cirrhosis pipeline products will be launched in the US and Ex-US till 2025.

SUMMARY:

  • Liver Cirrhosis phase 3 clinical trial pipeline products

  • Liver Cirrhosis phase 2 clinical trial pipeline products

  • Liver Cirrhosis phase 1 clinical trial pipeline products

  • Liver Cirrhosis preclinical research pipeline products

  • Liver Cirrhosis discovery stage pipeline products

  • Liver Cirrhosis pipeline products short-term launch highlights

Key Topics Covered:

1. Liver Cirrhosis Pipeline by Stages

2. Liver Cirrhosis Phase 3 Clinical Trial Insights

3. Liver Cirrhosis Phase 2 Clinical Trial Insights

4. Liver Cirrhosis Phase 1 Clinical Trial Insights

5. Liver Cirrhosis Preclinical Research Insights

6. Liver Cirrhosis Discovery Stage Insights

7. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/880kw

View source version on businesswire.com: https://www.businesswire.com/news/home/20210121005367/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Latest Stories

  • Myanmar coup: Facebook, Instagram place immediate ban on military

    Facebook said deadly violence in Myanmar had brought about the need for the ban on the military.

  • Medical oxygen scarce in Africa, Latin America amid virus

    A crisis over the supply of medical oxygen for coronavirus patients has struck nations in Africa and Latin America, where warnings went unheeded at the start of the pandemic and doctors say the shortage has led to unnecessary deaths. It takes about 12 weeks to install a hospital oxygen plant and even less time to convert industrial oxygen manufacturing systems into a medical-grade network. The gap in medical oxygen availability “is one of the defining health equity issues, I think, of our age,” said Peter Piot, director of the London School of Hygiene & Tropical Medicine, who said he survived a severe coronavirus infection thanks to the oxygen he received.

  • Exxon Mobil's total reserves drop by a third after COVID-19 oil price drop

    The largest U.S. oil producer is reeling from the sharp decline in oil demand and a series of bad bets on projects when prices were much higher. Exxon's reserves are at their lowest since the merger between Exxon and Mobil in 1999 and were "a result of very low prices during 2020 and the effects of reductions in capital expenditures," the company said in a filing. Total reserves for all products fell to 15.2 billion barrels of oil and gas at the end of 2020 from 22.4 billion the year before, mostly driven by oil sands in Canada and U.S. shale gas properties, according to the filing.

  • Boeing working with regulators, customers on return of 737 MAX in Asia - exec

    Boeing Co is working with regulators and customers to return the 737 MAX to the skies in Asia, a senior executive said on Thursday, where it remains grounded nearly two years after two deadly crashes even though it has returned in other markets. "We're continuing to work with global regulators and our customers to return the 737 MAX to service worldwide," Boeing Vice President Commercial Marketing Darren Hulst told reporters during a briefing on the Southeast Asian market.

  • Full text: Facebook bans Myanmar military from its platform with 'immediate effect'

    Facebook has also banned military-controlled state and media entities, and ads from military-linked commercial entities.

  • Virtual work parties: the good, the bad and the plain peculiar

    Companies are turning to events organisers to create virtual social events for staff. After almost a year of doing her job from home, fintech worker Catharina Gehrke was finally able to get some proper office gossip in the virtual bathroom and smoking area at her company's online Christmas party. The event she attended included a (virtual) taxi ride and dance floor, a Queen Elizabeth II impersonator, a cocktail-making class, plus (real) food and drink hampers delivered to the 200 party people - the staff stuck at home.

  • Oxfam’s statutory supervision lifted after reforms due to Haiti inquiry

    The Charity Commission for England and Wales found a ‘culture of poor behaviour’ among staff sent to help victims of the 2010 earthquake.

  • Hrithik Roshan likely to be summoned by Mumbai Police to record statement in imposter case involving Kangana Ranaut

    Hrithik Roshan had filed a complaint against an unknown imposter for allegedly speaking to actress Kangana Ranaut on his behalf using an email ID

  • Singapore: Police officer's wife admits to killing Myanmar maid

    The domestic helper from Myanmar was reportedly tortured and starved before her death.

  • Toolkit Case: Shantanu Granted Protection From Arrest Till 9 March

    The Delhi Police sought more time to file a detailed reply on Shantanu Muluk’s anticipatory bail plea.

  • Axa posts 18% net income drop as COVID-19 claims weigh

    Axa, Europe's second-biggest insurer after Allianz, on Thursday reported a 18% drop in net income last year as COVID-19 related claims hit earnings at its property and casualty insurance business. Axa said that claims for business interruption and event cancellations due to the new coronavirus outbreak amounted to 1.5 billion euros, unchanged from a previous estimate. "The impact from further lockdown measures in 2H20 was broadly neutral", Axa said in a statement.

  • UPDATE 1-France's Safran sees gradual recovery after crisis-hit 2020

    France's Safran predicted a gradual recovery from the aviation industry's worst crisis, after seeing demand for its jet engines and services drop sharply last year. Operating margin dropped 530 basis points to 10.2%. For 2021, Safran expects this key profitability gauge to improve by more than 100 basis points, with the recovery kicking in from the third quarter.

  • Anthony Joshua: ‘My legacy should be about the type of character I am’

    Even a long-mooted £100m fight on the horizon can’t faze Anthony Joshua, his dedication stretching beyond boxing into everything he does in his life. He talks to Susannah Butter about hopes for his legacy

  • Number of Hong Kong residents moving to Taiwan nearly doubles in 2020

    Number of Hong Kong residents moving to Taiwan nearly doubles in 2020. Wave of migration comes amid worsening crackdown on freedoms following the introduction of Beijing’s national security law

  • Betrayal and corporate avarice are bent to steal an emotionally disturbed scientist’s discovery of the cure to the common cold

    ‘Catching Cold: Vol 1 – Breakthrough: Hearts must first break to strengthen (A precovid-19 novel)’ released CHANDLER, Ariz., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Lem Moyé wanted to give the lay reader the chance to understand viruses and the immune system, while also showing them that scientists are not automatons but people with a full panoply of problems. It is for this reason he has written “Catching Cold: Vol 1 – Breakthrough: Hearts must first break to strengthen (A precovid-19 novel)” (published by Trafford Publishing). Doctor Jon DeLeon, an inspired scientist plagued by emotional addictions, believes that he can cure the common cold. His motley group of eccentric and intense scientists under the name CiliCold stumble, fight and work together to test Jon’s hypothesis. These efforts lead to repeated failure, and their support team becomes disillusioned by the repeated difficulties. Attorneys Jasper Giles and Cassie Rhodes, ruthless defenders of the SSS Pharmaceutical Company, learn of Dr. DeLeon’s ideas through the brutal deposition of CiliCold’s ex-accountant. Intrigued by the promise of Jon’s work, they infiltrate the company to learn that Jon’s imminent emotional collapse and financial ruin blind him to the crippling assault the lawyers are prepared to unleash. Only the final staggering observation of Jon and his team, together with the dogged resistance of another takeover target of SSS, can possibly preserve the finding of overwhelming scientific significance for which no one is prepared. “This novel focuses on behavioral disorders, emotional interactions between scientists and immunology. It demonstrates that scientists driven by intellect but riven by emotions are the most interesting of people. The public will also realize the impact of viruses on their daily lives and the need for vaccines and treatment,” Moyé says. When asked what he wants readers to take away from the book, Moyé answers, “That immunology is understandable but that the emotional problems of scientists are worthy of attention.” For more details about the book, please visit https://www.trafford.com/Bookstore/BookDetail.aspx?BookId=SKU-001278418 “Catching Cold: Vol 1 – Breakthrough: Hearts must first break to strengthen (A precovid-19 novel)” By Lem Moyé Hardcover | 6 x 9in | 406 pages | ISBN 9781698705477 Softcover | 6 x 9in | 406 pages | ISBN 9781698705453 E-Book | 406 pages | ISBN 9781698705460 Available at Amazon and Barnes & Noble About the Author Dr. Lem Moyé, M.D., Ph.D. is a physician, epidemiologist and biostatistician. After receiving his M.D. at the Indiana University Medical School, he completed post-doctoral training at Purdue University and the University of Texas. Dr. Moyé has conducted federally sponsored research for over 30 years, including 12 years investigating cell therapy for heart disease. He has published over 220 manuscripts, 11 books including two novels, and has worked with both the US FDA, and pharmaceutical companies. Dr. Moyé has taught graduate classes in epidemiology and biostatistics for three decades and has served as an expert witness in both state and federal court. He served as a volunteer physician during the Hurricane Katrina calamity, and his memories of that experience led to his prize winning book, “Caring for Katrina’s Survivors.” Trafford Publishing, an Author Solutions, LLC, author services imprint, was the first publisher in the world to offer an “on-demand publishing service,” and has led the independent publishing revolution since its establishment in 1995. Trafford was also one of the earliest publishers to utilize the Internet for selling books. More than 10,000 authors from over 120 countries have utilized Trafford’s experience for self publishing their books. For more information about Trafford Publishing, or to publish your book today, call 844-688-6899 or visit trafford.com. Attachment Cover_l CONTACT: Marketing Services Trafford Publishing 844-688-6899 authormarketingservices@trafford.com

  • U.N calls April meeting for talks over divided Cyprus

    The United Nations will convene a meeting of parties in the Cyprus dispute in Geneva in April, the first such meeting since 2017 when previous talks on the conflict collapsed in disarray. "The purpose of the meeting will be to determine whether common ground exists for the parties to negotiate a lasting solution to the Cyprus problem within a foreseeable horizon," said Stephane Dujarric, spokesman for U.N. Secretary-General Antonio Guterres. The meeting will take place in Geneva, Switzerland, from April 27 to 29, Dujarric said in a written statement.

  • Man survives 14 hours in Pacific Ocean 'clinging to sea rubbish'

    Vidam Perevertilov's decision to swim towards a "black dot" - a fishing buoy - saved his life.

  • South Africa's Woolworths posts first jump in half-year profit since 2015

    South African retailer Woolworths Holdings Ltd reported a 58.3% jump in first-half profit on Thursday, its first in five years, as sales recovered from the lows at the start of the COVID-19 pandemic. The apparel sector, worst-hit among retail sectors in South Africa and Australia at the start of the pandemic, recovered slightly from May as lockdowns lifted and retailers gave discounts to attract shoppers. But lower store footfall, particularly in large shopping centres and airport locations, significant drop in demand for formal wear and a return of restrictions in Australia has put clothing sales back on shaky ground.

  • Ghanaian LGBTQ+ centre closes after threats and abuse

    Ghanaian LGBTQ+ centre closes after threats and abuse. Founder says community centre in Accra was closed pre-emptively to protect its staff

  • Ukraine faces almost 40% jump in new daily COVID-19 cases

    Ukraine has registered an almost 40% jump in new coronavirus cases over the past 24 hours, Health Minister Maksym Stepanov said, just as the country starts its COVID-19 inoculation. A total of 8,147 cases were registered on Wednesday, the highest figure since mid-January when the number of new cases stood at 8,199, Stepanov said on Facebook. There were 5,850 new cases as of Feb. 24.